Insights

Washington – January 3, 2022: Crowell & Moring elected 13 lawyers to the firm’s partnership, effective January 1, 2022. The firm also promoted seven to the position of senior counsel and 19 associates to the position of counsel. The new partners have been promoted from within the ranks of the firm’s London, New York, and Washington, D.C. offices and from across several practice groups, including Advertising & Media; Antitrust & Competition; Corporate; Energy; Environment & Natural Resources; Government Contracts; Health Care; Technology & Intellectual Property; International Dispute Resolution; Litigation; Mass Tort, Product, and Consumer Litigation; and Privacy & Cybersecurity.

Washington – December 21, 2020: Crowell & Moring advised Olam International Limited (OIL) in its acquisition of the US-based chile pepper business (CPB) of Mizkan America, Inc., a major maker of condiments and sauces, for US$108.5 million. New Mexico-based CPB is one of the world’s leading suppliers of premium green chiles, jalapeños, and enchilada sauces. This acquisition, conducted through OIL’s subsidiary, Olam Americas Inc., is the first major acquisition for Olam Food Ingredients (OFI), the new operating group created after the reorganization within OIL earlier this year. The transaction is subject to US antitrust regulatory approval and customary closing conditions, which are expected to complete in January 2021

Enbrel (etanercept) is one of the best-selling biologic drugs in the United States, approved to treat rheumatoid arthritis and other serious inflammatory conditions. Etanercept was launched as Enbrel in 1998 as a treatment for moderate to severe rheumatoid arthritis, and was later approved to treat additional inflammatory diseases including plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and polyarticular juvenile idiopathic arthritis.  

Algorithmic pricing tools commonly used by businesses to increase efficiency and profits are under increasing antitrust scrutiny. This summer, federal regulators, state attorneys general, and state legislatures grappled with competing businesses providing nonpublic, competitively sensitive data to common algorithmic platforms. The Third Circuit deepened an emerging circuit split with the Ninth Circuit on algorithmic pricing liability, reviving antitrust claims against Atlantic City casino-hotels in a decision with direct implications for any company that uses a common pricing platform. See Crowell’s recent client alert. And New Jersey enacted two landmark laws—the FAIR Act and the Fair Price Protection Act—directly regulating algorithmic rent-setting and surveillance pricing. See Crowell’s recent client alert.

On March 19, 2026, a U.S. District Court for the Fifth Circuit panel denied the Federal Trade Commission’s (FTC) emergency motion for a stay pending appeal of a district court’s order that vacated the FTC’s 2024 overhaul of the HSR premerger notification form.